Viking Therapeutics (VKTX) Interest Coverage Ratio (2014 - 2015)
Viking Therapeutics' (VKTX) quarterly Interest Coverage Ratio came in at 13.08 in Q1 2015, up 83.94% year-over-year from 7.11 in Q1 2014, and up 83.94% quarter-over-quarter from 81.42 in Q1 2014.
Powered by 
Analysis
Viking Therapeutics (VKTX) Interest Coverage Ratio (2014 - 2015) Analysis & Trends
Viking Therapeutics has disclosed Interest Coverage Ratio across 2 years of filings, most recently posting 13.08 for Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | - |
API Access
Viking Therapeutics Interest Coverage Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-coverage-ratio", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();